Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Jun 15;21(12):2646-50.
doi: 10.1093/hmg/dds089. Epub 2012 Mar 2.

Mutation of the parkinsonism gene ATP13A2 causes neuronal ceroid-lipofuscinosis

Jose Bras  1 , Alain Verloes, Susanne A Schneider, Sara E Mole, Rita J Guerreiro
Affiliations

Mutation of the parkinsonism gene ATP13A2 causes neuronal ceroid-lipofuscinosis

Jose Bras et al. Hum Mol Genet. .

Abstract

Neuronal ceroid lipofuscinoses (NCLs) comprise a heterogeneous group of metabolic storage diseases that present with the accumulation of autofluorescent lipopigment, neurodegeneration and premature death. Nine genes have been thus far identified as the cause of different types of NCL, with ages at onset ranging from around birth to adult, although the underlying etiology of the disease still remains elusive. We present a family with typical NCL pathology in which we performed exome sequencing and identified a single homozygous mutation in ATP13A2 that fully segregates with disease within the family. Mutations in ATP13A2 are a known cause of Kufor-Rakeb syndrome (KRS), a rare parkinsonian phenotype with juvenile onset. These data show that NCL and KRS may share etiological features and implicate the lysosomal pathway in Parkinson's disease.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Pedigree of the family studied. Pedigree showing complete segregation of p.M810R mutation in ATP13A2 in the available family members. T is the reference allele, while G represents the mutation.
Figure 2.
Figure 2.
Identification of a homozygous mutation in ATP13A2. Figure showing the region on chromosome 1 where ATP13A2 is located, with the coverage and variant calling obtained from exome sequencing at the p.M810R locus for one affected sibling. Also shown are Sanger sequencing traces for one affected and two unaffected samples from the family and the protein sequence comparison displaying high conservation between species. The top panel on the chromatogram shows the affected individual (homozygous G at the position), while the two bottom panels show unaffected individuals (one homozygous wild-type and one heterozygous).
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Mole S.E., Williams R.E., Goebel H.H. The Neuronal Ceroid Lipofuscinoses (Batten Disease) Oxford: Oxford University Press; 2011.
    1. Wohlke A., Philipp U., Bock P., Beineke A., Lichtner P., Meitinger T., Distl O. A one base pair deletion in the canine ATP13A2 gene causes exon skipping and late-onset neuronal ceroid lipofuscinosis in the Tibetan terrier. PLoS Genet. 2011;7:e1002304. doi:10.1371/journal.pgen.1002304. - DOI - PMC - PubMed
    1. Farias F.H., Zeng R., Johnson G.S., Wininger F.A., Taylor J.F., Schnabel R.D., McKay S.D., Sanders D.N., Lohi H., Seppala E.H., et al. A truncating mutation in ATP13A2 is responsible for adult-onset neuronal ceroid lipofuscinosis in Tibetan terriers. Neurobiol. Dis. 2011;42:468–474. doi:10.1016/j.nbd.2011.02.009. - DOI - PubMed
    1. Ramirez A., Heimbach A., Grundemann J., Stiller B., Hampshire D., Cid L.P., Goebel I., Mubaidin A.F., Wriekat A.L., Roeper J., et al. Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase. Nat. Genet. 2006;38:1184–1191. doi:10.1038/ng1884. - DOI - PubMed
    1. Anderson G., Smith V.V., Malone M., Sebire N.J. Blood film examination for vacuolated lymphocytes in the diagnosis of metabolic disorders; retrospective experience of more than 2,500 cases from a single centre. J. Clin. Pathol. 2005;58:1305–1310. doi:10.1136/jcp.2005.027045. - DOI - PMC - PubMed

Publication types

Substances

Supplementary concepts